Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.

@article{Pacher1998ReviewOC,
  title={Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.},
  author={P{\'a}l Pacher and Zoltan Ungvari and Val{\'e}ria Kecskem{\'e}ti and Susanna Furst},
  journal={Current medicinal chemistry},
  year={1998},
  volume={5 5},
  pages={
          381-90
        }
}
Fluoxetine is an antidepressant drug, a potent and specific inhibitor of serotonin reuptake (SSRI). Evidence suggests that being compared with tricyclic antidepressants, fluoxetine may cause significantly fewer anticholinergic, antihistaminergic and cardiotoxic side effects in the treatment of major depressive disorders. Chronic treatment with fluoxetine was not reported to affect the electrocardiogram (ECG). There is no clinical evidence of conduction delay and very little evidence of… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis

  • Medical science monitor : international medical journal of experimental and clinical research
  • 2011
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2012
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND

Similar Papers

Loading similar papers…